---
title: CDMOs offering Solid-State Chemistry & Polymorph Screening with Oligonucleotide
path: /explore/solid-state-chemistry/oligonucleotide
companies_count: 8
---

# CDMOs offering Solid-State Chemistry & Polymorph Screening with Oligonucleotide

8 published CDMOs match Solid-State Chemistry & Polymorph Screening and Oligonucleotide.

Locations in this set include United States, China, Switzerland, United Kingdom, Asia, and India.

Capabilities that show up most often in this set: Process Development, CMC Analytical Development, API Synthesis & Manufacturing, Small Molecule Development & Manufacturing, and Formulation Development.

## Matching companies

- [Almac Group](/companies/almacgroup)
  - Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities.
- [CatSci](/companies/catsci)
  - UK-based partner for small molecule and complex synthetic medicines, offering route selection, process development, GMP drug substance manufacture and analytical services across four European and UK sites.
- [CordenPharma](/companies/cordenpharma)
  - Full-service CDMO offering cGMP development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligonucleotides, and oral solid dose across 10 facilities in 6 countries with 3000+ employees.
- [Crystec Limited (CrystecPharma)](/companies/crystecpharma)
  - Crystec Limited (CrystecPharma) is a pharmaceutical technology company that offers its mSAS® supercritical-fluid particle engineering platform to improve the bioavailability, stability and delivery of small and large molecule therapeutics. Its work is aimed at clients developing new and existing medicines.
- [PharmaBlock](/companies/pharmablock)
  - Leading provider of innovative chemistry products and services for pharmaceutical R&D and commercial manufacturing, with expertise in process development, GMP manufacturing, and low-carbon chemistry solutions.
- [Porton](/companies/portonpharma)
  - Porton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [Veranova](/companies/veranova)
  - Global CDMO specializing in development and manufacturing of complex active pharmaceutical ingredients (APIs), with expertise in solid form sciences, process development, and specialty modalities including ADCs and controlled substances.
